DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Decadron (Dexamethasone) - Vomiting - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Vomiting (29)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Decadron (Dexamethasone) where reactions include vomiting. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Decadron side effects in 69 year old male

Reported by a physician from Japan on 2012-07-10

Patient: 69 year old male, weighing 63.4 kg (139.6 pounds)

Reactions: Extradural Abscess, Vomiting, Abdominal Distension, Pyrexia, Enterocolitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Decadron
    Dosage: 2 mg, daily
    Administration route: Oral
    Start date: 2011-10-29

Oxycodone HCL
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-17

Oxycodone Hydrochloride
    Dosage: 5 mg, prn
    Administration route: Oral
    Indication: Pain
    Start date: 2010-11-11
    End date: 2011-05-05

Decadron
    Dosage: 0.5 mg, daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-08-25
    End date: 2011-09-26

Oxycodone Hydrochloride
    Dosage: 10 mg, prn
    Administration route: Oral
    Start date: 2011-05-06

Axitinib
    Dosage: 2 mg, bid
    Start date: 2010-12-14
    End date: 2011-07-14

Axitinib
    Dosage: 5 mg, bid
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Oxycodone HCL
    Dosage: 40 mg, bid
    Administration route: Oral
    Start date: 2011-05-07
    End date: 2011-06-16

Decadron
    Dosage: 1 mg, daily
    Administration route: Oral
    Start date: 2011-10-14
    End date: 2011-10-28

Other drugs received by patient: Hirudoid / 00723701 /; LAC B; Gasmotin; Olmesartan Medoxomil; Prorenal; Pursennid / 00142207 /; Norvasc; Teleminsoft; Mucosta; Amlodipine; Interferon Alfa; Mobic; Tizanidine Hydrochloride; Zometa; Veen D; Magnesium Oxide; Acetaminophen; Lansoprazole; Daikentyuto



Possible Decadron side effects in 69 year old male

Reported by a physician from Japan on 2012-07-06

Patient: 69 year old male, weighing 63.4 kg (139.6 pounds)

Reactions: Extradural Abscess, Vomiting, Abdominal Distension, Pyrexia, Enterocolitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Oxycodone HCL
    Dosage: 40 mg, bid
    Administration route: Oral
    Start date: 2011-05-07
    End date: 2011-06-16

Axitinib
    Dosage: 2 mg, bid
    Start date: 2010-12-14
    End date: 2011-07-14

Oxycodone Hydrochloride
    Dosage: 5 mg, prn
    Administration route: Oral
    Indication: Pain
    Start date: 2010-11-11
    End date: 2011-05-05

Oxycodone HCL
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-17

Decadron
    Dosage: 1 mg, daily
    Administration route: Oral
    Start date: 2011-10-14
    End date: 2011-10-28

Axitinib
    Dosage: 5 mg, bid
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Decadron
    Dosage: 0.5 mg, daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-08-25
    End date: 2011-09-26

Decadron
    Dosage: 2 mg, daily
    Administration route: Oral
    Start date: 2011-10-29

Oxycodone Hydrochloride
    Dosage: 10 mg, prn
    Administration route: Oral
    Start date: 2011-05-06

Other drugs received by patient: Mucosta; Norvasc; Amlodipine; Acetaminophen; Interferon Alfa; Gasmotin; Magnesium Oxide; Lansoprazole; Hirudoid / 00723701 /; LAC B; Pursennid / 00142207 /; Mobic; Veen D; Tizanidine Hydrochloride; Zometa; Daikentyuto; Teleminsoft; Olmesartan Medoxomil; Prorenal



Possible Decadron side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-27

Patient: female, weighing 86.7 kg (190.7 pounds)

Reactions: Back Pain, Spinal Compression Fracture, Vomiting, Nausea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decadron
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-07-01

Rituxan
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-07-01

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-07-01
    End date: 2011-07-11

Other drugs received by patient: Hydrocodone Bitartrate and Acetaminophen; Zofran; Clopidogrel Bisulfate; Senokot; Hydromorphone HCL; Soma; Tramadol HCL; Fentanyl Citrate; Hydrochlorothiazide; Lyrica; Robaxin; Docusate; Lansoprazole; Docusate Sodium; Prochlorperazine; Lorazepam; Plavix; Ondansetron (Zofran); Vitamin D; Pepcid; Diovan; Diphenhydramine HCL; Ativan; Actiq; Lipitor; Atorvastatin; Calcium; Dilaudid; Valtrex



Possible Decadron side effects in 69 year old male

Reported by a individual with unspecified qualification from Japan on 2012-06-25

Patient: 69 year old male

Reactions: Vomiting, Extradural Abscess, Abdominal Distension, Pyrexia, Enterocolitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Acetaminophen
    Dosage: 5 mg/bid
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Acetaminophen
    Dosage: 5 mg/bid
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-07-29
    End date: 2011-08-18

Acetaminophen
    Dosage: 5 mg/bid
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-08-27
    End date: 2011-09-26

Decadron
    Dosage: 0.5 mg/daily 1 mg/daily 2 mg/daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-10-14
    End date: 2011-10-28

Decadron
    Dosage: 0.5 mg/daily 1 mg/daily 2 mg/daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-06-18
    End date: 2011-08-24

Decadron
    Dosage: 0.5 mg/daily 1 mg/daily 2 mg/daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-08-25
    End date: 2011-10-13

Decadron
    Dosage: 0.5 mg/daily 1 mg/daily 2 mg/daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-10-29

Blinded Therapy
    Administration route: Oral
    Indication: Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Oxycodone HCL
    Dosage: 5 mg/prn 10 mg/prn
    Indication: Pain
    Start date: 2011-05-06

Oxycodone HCL
    Dosage: 5 mg/prn 10 mg/prn
    Indication: Pain
    Start date: 2010-11-11
    End date: 2011-05-05

Oxycontin
    Dosage: 40 mg/bid 50 mg/bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-05-07
    End date: 2011-06-16

Oxycontin
    Dosage: 40 mg/bid 50 mg/bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-17

Other drugs received by patient: Acetaminophen; DAI-Kenchu-TO; Mobic; Lansoprazole; Hirudoid; LAC-B; MG Oxide; Prorenal; Zometa; Gasmotin; MG Oxide; Pursennid (Senna); Teleminsoft; Tizanidine Hydrochloride; Mucosta; Norvasc; Olmesartan Medoxomil



Possible Decadron side effects in 69 year old male

Reported by a physician from Japan on 2012-06-15

Patient: 69 year old male, weighing 63.5 kg (139.6 pounds)

Reactions: Vomiting, Extradural Abscess, Abdominal Distension, Pyrexia, Enterocolitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Blinded Axitinib
    Dosage: 2 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Oxycodone Hydrochloride
    Dosage: 10 mg, as needed
    Administration route: Oral
    Start date: 2011-05-06

Decadron
    Dosage: 0.5 mg, 1x/day
    Administration route: Oral
    Start date: 2011-08-25
    End date: 2011-10-13

Oxycontin
    Dosage: 50 mg, 2x/day
    Administration route: Oral
    Start date: 2011-06-17

Axitinib
    Dosage: 5 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Axitinib
    Dosage: 5 mg, 2x/day
    Administration route: Oral
    Start date: 2011-07-29
    End date: 2011-08-18

Placebo
    Dosage: 2 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Decadron
    Dosage: 1 mg, 1x/day
    Administration route: Oral
    Start date: 2011-10-14
    End date: 2011-10-28

Axitinib
    Dosage: 5 mg, 2x/day
    Administration route: Oral
    Start date: 2011-08-27
    End date: 2011-09-26

Blinded NO Subject Drug
    Dosage: 2 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Decadron
    Dosage: unk mg, 1x/day
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-06-18
    End date: 2011-08-24

Oxycodone Hydrochloride
    Dosage: 5 mg, as needed
    Administration route: Oral
    Indication: Pain
    Start date: 2010-11-11
    End date: 2011-05-05

Decadron
    Dosage: 2 mg, 1x/day
    Administration route: Oral
    Start date: 2011-10-29

Oxycontin
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2011-05-07
    End date: 2011-06-16

Other drugs received by patient: Pursennid; Veen D; Amlodipine; LAC B; Tizanidine Hydrochloride; Teleminsoft; Acetaminophen; Mobic; Hirudoid; Olmesartan Medoxomil; DAI-Kenchu-TO; Norvasc; Magnesium Oxide; Lansoprazole; Hirudoid; Gasmotin; Mucosta; Prorenal; Zometa



Possible Decadron side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-04

Patient: 53 year old male, weighing 114.2 kg (251.2 pounds)

Reactions: Vomiting, Gastrointestinal Haemorrhage, International Normalised Ratio Increased, Hypotension, Asthenia, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decadron
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-09-13
    End date: 2010-11-05

Thalomid
    Dosage: 200 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-09-13
    End date: 2010-10-03

Velcade
    Dosage: 28 milligram
    Indication: Multiple Myeloma
    Start date: 2010-09-13
    End date: 2010-11-05

Other drugs received by patient: Vicodin; Celexa; Ferrous Gluconate; Florastor; Vitamin B-12; Allopurinol; Xanax; Lantus; Aredia; Lasix; Compazine; Humalog; Metoprolol Tartrate; Transfusion; Acetaminophen; Magnesium Chloride; Prilosec; Aranesp; Zofran; Kytril



Possible Decadron side effects in 85 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-30

Patient: 85 year old male, weighing 82.1 kg (180.6 pounds)

Reactions: Diabetes Mellitus, Oral Candidiasis, Interstitial Lung Disease, Acute Respiratory Distress Syndrome, Blood Creatinine Increased, Blood Urea Increased, Vomiting, Blood Chloride Decreased, Aortic Calcification, Atrial Fibrillation, Pancytopenia, Hyponatraemia, Mitral Valve Calcification, Brain Natriuretic Peptide Increased, Pernicious Anaemia, Dehydration, Mitral Valve Incompetence, Hypothyroidism, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 10 mg/daily/po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-01-31
    End date: 2011-02-13

Decadron
    Dosage: 40 mg/wky/
    Indication: Multiple Myeloma
    Start date: 2011-01-31
    End date: 2011-02-10

Doxil
    Dosage: 8 mg
    Indication: Multiple Myeloma
    Start date: 2011-01-31
    End date: 2011-02-10

Velcade
    Dosage: 2 mg
    Indication: Multiple Myeloma
    Start date: 2011-01-31
    End date: 2011-02-13

Other drugs received by patient: Procrit; Aspirin; Neurontin; Zometa; Ciprofloxacin; Thioctic Acid; Synthroid; Dflucan; Calcium (Unspecified); Levoxyl; Acyclovir



Possible Decadron side effects in female

Reported by a physician from United States on 2012-05-23

Patient: female, weighing 85.0 kg (187.0 pounds)

Reactions: Vomiting, Urinary Tract Infection, Pancytopenia, Clostridium Difficile Colitis, Dysfunctional Uterine Bleeding, Pelvic Pain, Fall, Decubitus Ulcer, Metastases To Bone, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: 2.7 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-11-08
    End date: 2012-02-24

Velcade
    Dosage: 2.7 mg, cyclic
    Start date: 2012-05-01

Decadron
    Dosage: 40 mg, cyclic
    Administration route: Oral
    Start date: 2012-05-01

Cytoxan

Decadron
    Dosage: 40 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma

Cytoxan
    Indication: Multiple Myeloma

Other drugs received by patient: Peridex / 00133002 /; Neurontin; Oxycodone Hydrochloride; Protonix; Antibiotics; Potassium Chloride; Oxycodone and Acetaminophen



Possible Decadron side effects in 45 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-18

Patient: 45 year old female

Reactions: Skin Chapped, Abdominal Pain, Muscle Atrophy, Headache, Erythema, Malaise, Bronchitis Viral, Ingrowing Nail, Localised Infection, Cushingoid, Pain in Extremity, Bursitis, LIP Ulceration, Myopathy, Breast Cancer Metastatic, Joint Swelling, Rash Maculo-Papular, Metastases To Central Nervous System, Purulent Discharge, Skin Toxicity, Scab, Fatigue, Skin Ulcer, Chest Pain, Dizziness, Abdominal Distension, Oedema, Coordination Abnormal, Gastrooesophageal Reflux Disease, Rash Pustular, Vomiting, Gastrointestinal Toxicity, Muscular Weakness, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, DRY Skin, Diarrhoea, Gait Disturbance

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Lapatinib
    Indication: Breast Cancer Metastatic
    Start date: 2011-03-04

Decadron
    Administration route: Oral
    Indication: Metastases To Central Nervous System

Capecitabine
    Indication: Breast Cancer Metastatic
    Start date: 2011-03-04

Acyclovir

Other drugs received by patient: Herceptin; Zoledronate Disodium



Possible Decadron side effects in 43 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-14

Patient: 43 year old female, weighing 79.0 kg (173.8 pounds)

Reactions: Confusional State, Drug Ineffective, Mouth Ulceration, Headache, Treatment Noncompliance, Nail Infection, Fatigue, Urinary Tract Disorder, Balance Disorder, Dyspepsia, Ingrowing Nail, Oedema, Food Craving, Pyuria, Drooling, Vomiting, Nausea, Hypoaesthesia, Neutrophilia, Aggression, Dysarthria, Breast Cancer Metastatic, Diarrhoea, Pollakiuria, Tooth Disorder

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decadron
    Administration route: Oral

Decadron
    Administration route: Oral
    Start date: 2011-10-03
    End date: 2011-10-12

Decadron
    Administration route: Oral

Etoposide
    Indication: Brain Cancer Metastatic
    Start date: 2011-10-24

Decadron
    Administration route: Oral
    Indication: Metastases To Central Nervous System

Decadron
    Administration route: Oral

Carboplatin
    Indication: Breast Cancer Metastatic
    Start date: 2011-10-24

Decadron Phosphate

Capecitabine
    Dosage: 2 weeks out of every 3
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-02-22
    End date: 2011-02-23

Capecitabine
    Dosage: 2 weeks out of every 3
    Administration route: Oral
    Start date: 2011-03-14

Other drugs received by patient: Lapatinib



Possible Decadron side effects in 75 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-10

Patient: 75 year old male, weighing 58.0 kg (127.6 pounds)

Reactions: Vomiting, Nausea, Dehydration, Blood Glucose Increased, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Metformin HCL
    Start date: 2012-03-07

Decadron
    Indication: Premedication
    Start date: 2012-02-08

Megace
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2012-04-12

Other drugs received by patient: Lovastatin; Insulin; Kytril; Aspirin; Centrum; Vitamin B-12



Possible Decadron side effects in

Reported by a individual with unspecified qualification from United States on 2012-05-10

Patient:

Reactions: Vomiting, Nausea, Dehydration, Asthenia, Blood Glucose Increased, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decadron
    Dosage: 20 mg, every 2 weeks
    Indication: Chemotherapy
    Start date: 2012-02-08

GS-6624 VS Placebo
    Dosage: 700 mg, every 2 weeks
    Indication: Colorectal Cancer
    Start date: 2012-02-08

Folfiri
    Dosage: unk, every 2 weeks
    Indication: Colorectal Cancer
    Start date: 2012-02-08

Megestrol Acetate
    Dosage: 0.400 mg, bid
    Administration route: Oral
    Indication: Decreased Appetite
    Start date: 2012-04-12

Other drugs received by patient: Metformin HCL; Lovastatin; Centrum / 00554501 /; Vitamin B12 NOS; Kytril; Insulin; Aspirin



Possible Decadron side effects in female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-08

Patient: female

Reactions: Skin Chapped, Abdominal Pain, Muscle Atrophy, Headache, Erythema, Malaise, Bronchitis Viral, Ingrowing Nail, Localised Infection, Cushingoid, Pain in Extremity, Bursitis, LIP Ulceration, Myopathy, Joint Swelling, Metastases To Central Nervous System, Rash Maculo-Papular, Purulent Discharge, Scab, Skin Toxicity, Death, Fatigue, Skin Ulcer, Chest Pain, Dizziness, Abdominal Distension, Oedema, Coordination Abnormal, Gastrooesophageal Reflux Disease, Rash Pustular, Vomiting, Gastrointestinal Toxicity, Muscular Weakness, Palmar-Plantar Erythrodysaesthesia Syndrome, DRY Skin, Rash, Diarrhoea, Gait Disturbance

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Capecitabine
    Indication: Breast Cancer Metastatic
    Start date: 2011-03-04

Decadron
    Administration route: Oral
    Indication: Metastases To Central Nervous System

Acyclovir

Lapatinib
    Indication: Breast Cancer Metastatic
    Start date: 2011-03-04

Other drugs received by patient: Herceptin; Zoledronate Disodium



Possible Decadron side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-07

Patient: female, weighing 85.0 kg (187.0 pounds)

Reactions: Vomiting, Urinary Tract Infection, Pancytopenia, Clostridium Difficile Colitis, Dysfunctional Uterine Bleeding, Pelvic Pain, Fall, Decubitus Ulcer, Metastases To Bone, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decadron
    Dosage: 40 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma

Velcade
    Dosage: 2.7 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-11-08
    End date: 2012-02-24

Cytoxan
    Indication: Multiple Myeloma

Other drugs received by patient: Antibiotics; Protonix; Peridex / 00133002 /; Oxycodone and Acetaminophen; Oxycodone HCL; Neurontin; Potassium Chloride



Possible Decadron side effects in female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-03

Patient: female

Reactions: Confusional State, Drug Ineffective, Mouth Ulceration, Headache, Nail Infection, Treatment Noncompliance, Fatigue, Urinary Tract Disorder, Dyspepsia, Balance Disorder, Ingrowing Nail, Oedema, Food Craving, Pyuria, Drooling, Vomiting, Nausea, Hypoaesthesia, Neutrophilia, Aggression, Dysarthria, Breast Cancer Metastatic, Diarrhoea, Pollakiuria, Tooth Disorder

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decadron
    Administration route: Oral

Carboplatin
    Indication: Breast Cancer Metastatic
    Start date: 2011-10-24

Lapatinib
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-02-22
    End date: 2011-09-21

Decadron Phosphate

Etoposide
    Indication: Brain Cancer Metastatic
    Start date: 2011-10-24

Decadron
    Administration route: Oral
    Indication: Metastases To Central Nervous System

Decadron
    Administration route: Oral

Decadron
    Administration route: Oral

Decadron
    Administration route: Oral
    Start date: 2011-10-03
    End date: 2011-10-12

Capecitabine
    Dosage: 2 weeks out of every 3
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-02-22
    End date: 2011-02-23

Capecitabine
    Dosage: 2 weeks out of every 3
    Administration route: Oral
    Start date: 2011-03-14



Possible Decadron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-05

Patient:

Reactions: Vomiting, Dyspnoea, Haemorrhage, Nausea, Urinary Tract Infection, Systolic Dysfunction, Hypercholesterolaemia, Chest Pain, Pulmonary Oedema, Acute Myocardial Infarction, Adrenal Mass

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zometa

Decadron

Velcade



Possible Decadron side effects in 69 year old male

Reported by a physician from Japan on 2012-02-29

Patient: 69 year old male, weighing 63.4 kg (139.6 pounds)

Reactions: Vomiting, Extradural Abscess, Abdominal Distension, Pyrexia, Enterocolitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Oxycodone HCL
    Dosage: 40 mg, bid
    Administration route: Oral
    Start date: 2011-05-07
    End date: 2011-06-16

Decadron
    Dosage: 1 mg, daily
    Administration route: Oral
    Start date: 2011-10-14
    End date: 2011-10-28

Decadron
    Dosage: 0.5 mg, daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-08-25
    End date: 2011-09-26

Axitinib
    Dosage: 5 mg, bid
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Oxycodone HCL
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-17

Axitinib
    Dosage: 2 mg, bid
    Start date: 2010-12-14
    End date: 2011-07-14

Oxycodone HCL
    Dosage: 10 mg, prn
    Indication: Pain
    Start date: 2011-05-06

Decadron
    Dosage: 2 mg, daily
    Administration route: Oral
    Start date: 2011-10-29

Other drugs received by patient: Zometa; Mucosta; Daikentyuto; Teleminsoft; Lansoprazole; Acetaminophen; Prorenal; Veen D; Gasmotin; Interferon Alfa; Magnesium Oxide; LAC B; Mobic; Tizanidine HCL; Pursennid / 00142207 /; Hirudoid / 00723701 /; Olmesartan Medoxomil; Amlodipine; Norvasc



Possible Decadron side effects in 69 year old male

Reported by a physician from Japan on 2012-02-23

Patient: 69 year old male

Reactions: Vomiting, Diplegia, Pyrexia, Extradural Abscess, Sensory Disturbance, Abdominal Distension, Enterocolitis, White Blood Cell Count Increased, Decreased Appetite

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Oxycontin
    Dosage: 40;50 mg/bid, po
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-17

Oxycontin
    Dosage: 40;50 mg/bid, po
    Administration route: Oral
    Indication: Pain
    Start date: 2011-05-07
    End date: 2011-06-16

Blinded Therapy
    Dosage: 40;50 po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Decadron
    Dosage: 0.5; 1; 2 po
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-10-29

Decadron
    Dosage: 0.5; 1; 2 po
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-08-25
    End date: 2011-10-13

Decadron
    Dosage: 0.5; 1; 2 po
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-06-18
    End date: 2011-08-24

Decadron
    Dosage: 0.5; 1; 2 po
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-10-14
    End date: 2011-10-28

Oxycodone Hydrochloride
    Dosage: 10 mg/prn
    Indication: Pain
    Start date: 2011-05-06

Axitinib
    Dosage: 5 mg/bid, po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-08-27
    End date: 2011-09-26

Axitinib
    Dosage: 5 mg/bid, po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-07-29
    End date: 2011-08-18

Axitinib
    Dosage: 5 mg/bid, po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Other drugs received by patient: DAI-Kenchu-TO; Hirudoid; Acetaminophen; Mobic; Norvasc; Teleminsoft; Lansoprazole; LAC-B; Prorenal; Tizanidine HCL; Zometa; Mucosta; Olmesartan Medoxomil; Gasmotin; MG Oxide; Pursennid (Senna)



Possible Decadron side effects in 69 year old male

Reported by a individual with unspecified qualification from Japan on 2012-02-15

Patient: 69 year old male

Reactions: Extradural Abscess, Vomiting, Stomatitis, Abdominal Distension, Pyrexia, Enterocolitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Decadron
    Dosage: unk;po, 0.5 mg/daily, 1 mg/daily, 2 mg/daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-08-25
    End date: 2011-10-13

Decadron
    Dosage: unk;po, 0.5 mg/daily, 1 mg/daily, 2 mg/daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-10-14
    End date: 2011-10-28

Decadron
    Dosage: unk;po, 0.5 mg/daily, 1 mg/daily, 2 mg/daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-10-29

Decadron
    Dosage: unk;po, 0.5 mg/daily, 1 mg/daily, 2 mg/daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-06-18
    End date: 2011-08-24

Blinded Therapy
    Dosage: unk;po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Oxycontin
    Dosage: 40 mg/bid;po, 50 mg/bid;po
    Administration route: Oral
    Indication: Pain
    Start date: 2011-05-07
    End date: 2011-06-16

Oxycontin
    Dosage: 40 mg/bid;po, 50 mg/bid;po
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-17

Axitinib
    Dosage: 5 mg/bid;po, 5 mg/bid;po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-07-29
    End date: 2011-08-18

Axitinib
    Dosage: 5 mg/bid;po, 5 mg/bid;po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-08-27
    End date: 2011-09-26

Axitinib
    Dosage: 5 mg/bid;po, 5 mg/bid;po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Oxycodone Hydrochloride
    Dosage: po
    Administration route: Oral
    Indication: Pain
    Start date: 2011-05-06

Other drugs received by patient: Hirudoid; MG Oxide; LAC-B; Mucosta; Prorenal; Gasmotin; Pursennid (Senna); DAI-Kenchu-TO; Teleminsoft; Zometa; Acetaminophen; Lansoprazole; Tizanidine HCL; Mobic; Norvasc; Olmesartan Medoxomil



Possible Decadron side effects in male

Reported by a physician from Japan on 2012-02-14

Patient: male, weighing 63.5 kg (139.6 pounds)

Reactions: Vomiting, Extradural Abscess, Abdominal Distension, Pyrexia, Enterocolitis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Decadron
    Dosage: unk mg, 1x/day
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-06-18
    End date: 2011-08-24

Axitinib
    Dosage: 5 mg, 2x/day
    Administration route: Oral
    Start date: 2011-08-27
    End date: 2011-09-26

Blinded NO Subject Drug
    Dosage: 2 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Axitinib
    Dosage: 5 mg, 2x/day
    Administration route: Oral
    Start date: 2011-07-29
    End date: 2011-08-18

Blinded Axitinib
    Dosage: 2 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Oxinorm
    Dosage: 10 mg, as needed
    Administration route: Oral
    Indication: Pain
    Start date: 2011-05-06

Decadron
    Dosage: 1 mg, 1x/day
    Administration route: Oral
    Start date: 2011-10-14
    End date: 2011-10-28

Oxycontin
    Dosage: 50 mg, 2x/day
    Administration route: Oral
    Start date: 2011-06-17

Blinded Placebo
    Dosage: 2 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Decadron
    Dosage: 2 mg, 1x/day
    Administration route: Oral
    Start date: 2011-10-29

Oxycontin
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2011-05-07
    End date: 2011-06-16

Axitinib
    Dosage: 5 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Decadron
    Dosage: 0.5 mg, 1x/day
    Administration route: Oral
    Start date: 2011-08-25
    End date: 2011-10-13

Other drugs received by patient: Norvasc; Lansoprazole; Tizanidine HCL; Gasmotin; Mobic; DAI-Kenchu-TO; Veen D; Pursennid; Acetaminophen; Zometa; Magnesium Oxide; Hirudoid; Olmesartan Medoxomil; Hirudoid; LAC B; Prorenal; Teleminsoft; Mucosta; Amlodipine



Possible Decadron side effects in 79 year old male

Reported by a individual with unspecified qualification from United Kingdom on 2012-01-30

Patient: 79 year old male

Reactions: Vomiting, Nausea, Dizziness Postural, Orthostatic Hypotension, Hyponatraemia, Toxicity To Various Agents, Constipation, Fall, Lower Respiratory Tract Infection, Abdominal Discomfort, Diarrhoea, Dehydration, Abdominal Distension, Gastrooesophageal Reflux Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: 2.6 mg/unk;iv
    Indication: Multiple Myeloma
    Start date: 2009-02-27

Velcade
    Dosage: 2.6 mg/unk;iv
    Indication: Multiple Myeloma
    Start date: 2009-04-10
    End date: 2009-04-20

Velcade
    Dosage: 2.6 mg/unk;iv
    Indication: Multiple Myeloma
    Start date: 2009-01-27

Velcade
    Dosage: 2.6 mg/unk;iv
    Indication: Multiple Myeloma
    Start date: 2009-05-01
    End date: 2009-05-04

Decadron
    Dosage: 20 mg/daily po, 20 mg/unk;po, 20 mg/daily;po, 20 mg/daily;po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-05-01
    End date: 2009-05-05

Decadron
    Dosage: 20 mg/daily po, 20 mg/unk;po, 20 mg/daily;po, 20 mg/daily;po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-02-27

Decadron
    Dosage: 20 mg/daily po, 20 mg/unk;po, 20 mg/daily;po, 20 mg/daily;po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-04-10
    End date: 2009-04-21

Decadron
    Dosage: 20 mg/daily po, 20 mg/unk;po, 20 mg/daily;po, 20 mg/daily;po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-01-27

Other drugs received by patient: Prednisolone; Simvastatin; Moviprep; Aspirin; Ramipril; Granisetron; Isosorbide Mononitrate; Persantin; Domperidone



Possible Decadron side effects in 69 year old male

Reported by a physician from Japan on 2012-01-18

Patient: 69 year old male, weighing 63.4 kg (139.6 pounds)

Reactions: Vomiting, Extradural Abscess, Abdominal Distension, Pyrexia, Enterocolitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Oxycodone HCL
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-17

Decadron
    Dosage: 1 mg, daily
    Administration route: Oral
    Start date: 2011-10-14
    End date: 2011-10-28

Decadron
    Dosage: 2 mg, daily
    Administration route: Oral
    Start date: 2011-10-29

Axitinib
    Dosage: 5 mg, bid
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Oxycodone HCL
    Dosage: 40 mg, bid
    Administration route: Oral
    Start date: 2011-05-07
    End date: 2011-06-16

Axitinib
    Dosage: 2 mg, bid
    Start date: 2010-12-14
    End date: 2011-07-14

Decadron
    Dosage: 0.5 mg, daily
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-08-25
    End date: 2011-09-26

Oxycodone HCL
    Dosage: 10 mg, prn
    Indication: Pain
    Start date: 2011-05-06

Other drugs received by patient: Acetaminophen; Mucosta; Veen D; Teleminsoft; Hirudoid / 00723701 /; Gasmotin; Pursennid / 00142207 /; Zometa; LAC B; Daikentyuto; Norvasc; Amlodipine; Prorenal; Mobic; Magnesium Oxide; Lansoprazole; Olmesartan Medoxomil; Tizanidine HCL



Possible Decadron side effects in 76 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-09

Patient: 76 year old female

Reactions: Vomiting, Abdominal Pain Upper

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decadron
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-11-08

Velcade
    Indication: Multiple Myeloma
    Start date: 2011-11-08

Other drugs received by patient: Domperidone; Doxasin; Acyclovir; Omeprazole; Aspirin; Atenolol



Possible Decadron side effects in 69 year old male

Reported by a individual with unspecified qualification from Japan on 2012-01-03

Patient: 69 year old male

Reactions: Abdominal Pain, Stomatitis, Vomiting, Flatulence, Chills, Pyrexia, Tumour Associated Fever, Extradural Abscess, Abdominal Distension, Enterocolitis, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Axitinib
    Dosage: 5 mg/bid/po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-07-29
    End date: 2011-08-18

Axitinib
    Dosage: 5 mg/bid/po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-11-16
    End date: 2011-07-14

Axitinib
    Dosage: 5 mg/bid/po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-08-27
    End date: 2011-09-26

Blinded Therapy
    Dosage: po
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2010-12-14
    End date: 2011-07-14

Oxycodone Hydrochloride
    Dosage: 10 mg/prn/po
    Administration route: Oral
    Indication: Pain
    Start date: 2011-05-06

Decadron
    Dosage: po, 0.5 mg/daily/po, 1 mg/daily/po, 2 mg/daily/po
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-08-25
    End date: 2011-10-11

Decadron
    Dosage: po, 0.5 mg/daily/po, 1 mg/daily/po, 2 mg/daily/po
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-10-14
    End date: 2011-10-28

Decadron
    Dosage: po, 0.5 mg/daily/po, 1 mg/daily/po, 2 mg/daily/po
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-06-18
    End date: 2011-08-24

Decadron
    Dosage: po, 0.5 mg/daily/po, 1 mg/daily/po, 2 mg/daily/po
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2011-10-29

Oxycontin
    Dosage: 40 mg/bid/po, 50 mg/bid/po
    Administration route: Oral
    Indication: Pain
    Start date: 2011-05-07
    End date: 2011-06-16

Oxycontin
    Dosage: 40 mg/bid/po, 50 mg/bid/po
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-17

Other drugs received by patient: Pursennid (Senna); Tizanidine HCL; Gasmotin; Prorenal; Teleminsoft; Zometa; Acetaminophen; Norvasc; LAC-B; Lansoprazole; Olmesartan Medoxomil; Mucosta; MG Oxide; DAI-Kenchu-TO; Hirudoid; Mobic



Possible Decadron side effects in 79 year old male

Reported by a individual with unspecified qualification from United Kingdom on 2011-12-08

Patient: 79 year old male

Reactions: Vomiting, Nausea, Hypotension, Duodenogastric Reflux, Hyponatraemia, Orthostatic Hypotension, Constipation, Lower Respiratory Tract Infection, Abdominal Discomfort, Diarrhoea, Intestinal Dilatation, Dehydration, Hypoxia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decadron
    Dosage: 20 mg/daily po ; 20 mg
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-01-27

Decadron
    Dosage: 20 mg/daily po ; 20 mg
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-02-27

Velcade
    Dosage: 2.6 mg iv ; 2.6 mg iv
    Indication: Multiple Myeloma
    Start date: 2009-02-27

Velcade
    Dosage: 2.6 mg iv ; 2.6 mg iv
    Indication: Multiple Myeloma
    Start date: 2009-01-27

Other drugs received by patient: Moviprep; Granisetron; Isosorbide Mononitrate; Prednisolone



Possible Decadron side effects in 79 year old male

Reported by a individual with unspecified qualification from United Kingdom on 2011-12-01

Patient: 79 year old male

Reactions: Vomiting, Nausea, Hyponatraemia, Lower Respiratory Tract Infection, Abdominal Discomfort, Diarrhoea, Dehydration, Abdominal Distension, Hypoxia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decadron
    Dosage: 20 mg/daily/po, 20 mg/po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-01-27

Decadron
    Dosage: 20 mg/daily/po, 20 mg/po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-02-27

Velcade
    Dosage: 2.6 mg/iv
    Indication: Multiple Myeloma
    Start date: 2009-02-27

Other drugs received by patient: Isosorbide Mononitrate; Granisetron; Prednisolone; Moviprep



Possible Decadron side effects in 82 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-29

Patient: 82 year old male

Reactions: Confusional State, RED Blood Cell Schistocytes Present, Flatulence, Tachycardia, Neoplasm Progression, Multiple Myeloma, Fall, Loss of Consciousness, Blood Calcium Decreased, Neuropathy Peripheral, Ecchymosis, Abdominal Distension, Dizziness, Gastrointestinal Sounds Abnormal, Blood Sodium Decreased, Hypovolaemia, Blood Glucose Increased, Blood Urea Increased, Vomiting, Nausea, Pain of Skin, Syncope, Diarrhoea, Dehydration, Asthenia, Elliptocytosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bortezomib
    Indication: Multiple Myeloma
    Start date: 2011-06-14
    End date: 2011-06-24

Bortezomib
    Indication: Multiple Myeloma
    Start date: 2011-07-05
    End date: 2011-07-15

Decadron
    Dosage: //po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-06-14

Study Drug (Unspecified)
    Dosage: 100 mg/ /iv
    Indication: Multiple Myeloma
    Start date: 2011-06-14
    End date: 2011-07-15

Other drugs received by patient: Metoprolol; Pamidronate Disodium; Potassium Chloride; Omeprazole; Lomotil; Simvastatin



Possible Decadron side effects in 82 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-18

Patient: 82 year old male

Reactions: Abdominal Pain, Flatulence, Tachycardia, Abdominal Tenderness, Ecchymosis, Gastrointestinal Sounds Abnormal, Blood Creatinine Increased, Clostridial Infection, Hypovolaemia, Pain of Skin, Hypotension, Hypoaesthesia, Dehydration, Normochromic Normocytic Anaemia, Elliptocytosis, Orthostatic Intolerance, Confusional State, Food Intolerance, RED Blood Cell Schistocytes Present, Neoplasm Progression, Multiple Myeloma, Fall, Blood Calcium Decreased, Neuropathy Peripheral, Abdominal Distension, Dizziness, Blood Sodium Decreased, Thrombocytopenia, Blood Glucose Increased, Blood Pressure Diastolic Decreased, Blood Urea Increased, Vomiting, Nausea, Amnesia, Diarrhoea, Presyncope, Hypophagia, Carbon Dioxide Decreased, Asthenia, Metastases To Bone

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decadron
    Dosage: unk/unk/po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-06-14

Bortezomib
    Dosage: unk/unk/unk
    Indication: Multiple Myeloma
    Start date: 2011-07-05
    End date: 2011-08-15

Bortezomib
    Dosage: unk/unk/unk
    Indication: Multiple Myeloma
    Start date: 2011-06-14
    End date: 2011-06-24

Other drugs received by patient: Potassium Chloride; Metoprolol Tartrate; Lomotil; Simvastatin; Omeprazole; Pamidronate Disodium



Possible Decadron side effects in 61 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2011-11-02

Patient: 61 year old male

Reactions: Haemoglobin Decreased, Vomiting, Dyspnoea, Septic Shock, Cardiac Arrest, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Navelbine
    Dosage: 32 mg iv
    Indication: non-Small Cell Lung Cancer
    Start date: 2008-12-02
    End date: 2009-01-13

Decadron
    Dosage: 4 mg bid po
    Administration route: Oral
    Indication: Vomiting
    Start date: 2008-12-21
    End date: 2009-01-19

Other drugs received by patient: Cisplatin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017